All news from Anaesthesiology

Zephyr Endobronchial Valve Approved to Treat Severe Emphysema

Pulmonx® Corp. announced that the U.S. Food and Drug Administration (FDA) has approved the Zephyr® Endobronchial Valve System for treating severe emphysema patients. The Zephyr Valve is the first minimally-invasive device approved in the United States for treating patients with severe emphysema, a progressive and life-threatening form of the chronic obstructive pulmonary disease (COPD).

Deadly Bacteria: Immunotherapy Against These Pathogens

Researchers have designed a strategy aimed at tagging Gram-negative bacteria for destruction via small molecule conjugates they have created that specifically home to bacterial cell surfaces and trigger an immune response. They observed a significant decrease in the number of live bacteria using their compound in experiments on E. coli in human serum.

Clinical Study of EV3D Drug Response Assay

KIYATEC, Inc. announced the enrollment of the first patients in a U.S. clinical study of its Ex Vivo 3D drug response assay (EV3D) across several difficult-to-treat solid tumors. The 3D-PREDICT clinical study has been initiated at the Cancer Institute of Greenville Health System (GHS) with the goal of recruiting 640 patients across additional clinical sites to be added in the future.